Virtual Reality

News

Sana strives for breakthrough designation as VR PTSD trial concludes

Sana selected Curavit as its VCRO for the decentralised clinical trial of its Sana virtual-reality device to treat symptoms of PTSD.

Jenna Philpott

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Sana strives for breakthrough designation as VR PTSD trial concludes

Leading lead generation providers and technology solutions for the clinical trials industry

Leading sales enablement, prospecting and automation providers and technology solutions for the clinical trials industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing